全文获取类型
收费全文 | 482469篇 |
免费 | 61822篇 |
国内免费 | 24219篇 |
专业分类
耳鼻咽喉 | 8289篇 |
儿科学 | 9343篇 |
妇产科学 | 6105篇 |
基础医学 | 38519篇 |
口腔科学 | 7413篇 |
临床医学 | 68652篇 |
内科学 | 91483篇 |
皮肤病学 | 11254篇 |
神经病学 | 29714篇 |
特种医学 | 18461篇 |
外国民族医学 | 155篇 |
外科学 | 74113篇 |
综合类 | 63498篇 |
现状与发展 | 148篇 |
一般理论 | 37篇 |
预防医学 | 32384篇 |
眼科学 | 11385篇 |
药学 | 36867篇 |
374篇 | |
中国医学 | 22942篇 |
肿瘤学 | 37374篇 |
出版年
2024年 | 1937篇 |
2023年 | 9470篇 |
2022年 | 14167篇 |
2021年 | 19538篇 |
2020年 | 18616篇 |
2019年 | 12523篇 |
2018年 | 18133篇 |
2017年 | 17785篇 |
2016年 | 18128篇 |
2015年 | 23790篇 |
2014年 | 34265篇 |
2013年 | 34126篇 |
2012年 | 32746篇 |
2011年 | 34876篇 |
2010年 | 30853篇 |
2009年 | 30705篇 |
2008年 | 25928篇 |
2007年 | 23283篇 |
2006年 | 24775篇 |
2005年 | 20347篇 |
2004年 | 14260篇 |
2003年 | 12314篇 |
2002年 | 10633篇 |
2001年 | 10738篇 |
2000年 | 9345篇 |
1999年 | 8959篇 |
1998年 | 6993篇 |
1997年 | 6810篇 |
1996年 | 5927篇 |
1995年 | 5665篇 |
1994年 | 4022篇 |
1993年 | 2834篇 |
1992年 | 3052篇 |
1991年 | 2847篇 |
1990年 | 2265篇 |
1989年 | 2246篇 |
1988年 | 1972篇 |
1987年 | 1680篇 |
1986年 | 1497篇 |
1985年 | 1221篇 |
1984年 | 806篇 |
1983年 | 729篇 |
1982年 | 645篇 |
1981年 | 561篇 |
1980年 | 464篇 |
1979年 | 469篇 |
1978年 | 408篇 |
1977年 | 475篇 |
1975年 | 328篇 |
1972年 | 340篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
P J Hayden C J Welsh Y Yang W H Schaefer A J Ward J L Stevens 《Chemical research in toxicology》1992,5(2):232-237
Nephrotoxic cysteine conjugates derived from a variety of halogenated alkenes are enzymatically activated via the beta-lyase pathway to yield reactive sulfur-containing metabolites which bind covalently to cellular macromolecules. Mitochondria contain beta-lyase enzymes and are primary targets for binding and toxicity. Previously, mitochondrial protein and/or DNA have been considered as molecular targets for cysteine conjugate metabolite binding. We now report that metabolites of nephrotoxic cysteine conjugates form covalent adducts with rat kidney mitochondrial phospholipids. Rat kidney mitochondria were incubated with the 35S-labeled conjugates S-(1,1,2,2-tetrafluoroethyl)-L-cysteine (TFEC), S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine (CTFC), S-(1,2-dichlorovinyl)-L-cysteine, and S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine. Quantitation of metabolite binding to whole mitochondria and to mitochondrial protein and lipid fractions revealed that as much as 42% of the 35S-label associated with the mitochondria was found in the lipid fraction. Total lipids were also extracted from 35S-treated mitochondria and separated by thin-layer chromatography. 35S-Containing metabolites were found in the lipid fractions from mitochondria treated with each of the conjugates. Lipids from both [35S]CTFC- and [35S]-TFEC-treated mitochondria contained major 35S-labeled lipid adducts which had similar mobility by thin-layer chromatography. Fatty acid analysis, 19F and 31P NMR spectroscopy, and mass spectrometric analyses confirmed that the major TFEC and CTFC adducts are thioamides of phosphatidylethanolamine. 相似文献
32.
33.
Birth weight on 12,644 singleton infants from 6,196 sibships born in Maryland between 1980 and 1984 were used to estimate the effects of nine maternal and infant covariates on the sibship correlation in birth weight. Assuming a homogeneous correlation across all families, the estimated intraclass correlation was 0.4664 (+/- 0.0099). This high sibship correlation makes it possible to predict, with reasonable accuracy, the birth weight of a child given information on previous sibs, as well as covariates on the mother and/or infant pertinent to a given pregnancy. The reduction in variance associated with incorporating information on the nine covariates used here was approximately equal to that obtained by conditioning on a single previous sib. Testing for heterogeneity in correlation among different groups of families showed that a crude measure of parity (first live birth vs. other), time between births, mother's marital status, and maternal age at the birth of the last child significantly influenced the sibship correlation in birth weight. 相似文献
34.
Peter Stone MD FRNZCOG FRCOG David Cook FRNZCOG MRCOG John Hutton PhD FRNZCOG FRCOG Gordon Purdie BSc Henry Murray MD FRNZCOG MRCOG Lauren Harcourt MPP BA 《The Australian & New Zealand journal of obstetrics & gynaecology》1995,35(1):32-37
Summary: This is the first report of the largest study of blood pressure measurement in pregnancy in a New Zealand population using standardized definitions and methodology. Over 3,800 women who delivered in an 8-month period in the Wellington region were included in the study. Blood pressure measurement and the presence of oedema and proteinuria were recorded from booking until delivery and in the puerperium. Only 2.7% of women were unable to be contacted after delivery for details on outcomes. The results established normal ranges for blood pressure throughout pregnancy. The data show that Mood pressure greater than 140/90 until 35 weeks' gestation is outside 2 standard deviations at all gestations and justifies using these measurements as the definition of hypertension in pregnancy. The fall in blood pressure in the 2nd trimester was less than 1 mm Ffg per week in both the systolic and diastolic pressures. This fall was smaller than previously recorded in other studies. Gestational hypertension was the commonest blood pressure abnormality occurring in 15.2% of the population. This represented 69% of the pregnant women with a hypertensive disorder. The overall incidence of both gestational hypertension and preeclampsia was 18.5% which is higher than reported in other parts of the world. In this study obesity was significantly associated with hypertensive disorders in pregnancy. An arm circumference of >33 cm, one of the measurements of obesity, was found in 6.8% of the study population. Even after the effect of arm circumference was taken into account, hypertensive disorders were also more common in Pacific Island women. Ankle oedema was significantly associated with the development of both gestational hypertension and preeclampsia but the incidence of oedema was noted in only 11.9% of the subjects. 相似文献
35.
Alexandros Karabetsos MD Dr ; George Karachalios MD Dr ; Paraskevoula Bourlinou RN Nurse ; Asimina Reppa RN Nurse ; Rozeta Koutri MD Dr ; Androniki Fotiadou MD Dr 《Headache》1997,37(1):12-14
The efficacy and safety of ketoprofen and paracetamol were compared for the treatment of acute migraine in a randomized, double-blind study of 64 patients. Thirty-four patients received ketoprofen 100 mg intramuscularly, and 30 patients received paracetamol 500 mg intramuscularly. Partial or complete relief of pain and other symptoms was achieved 15 to 20 minutes after administration in the ketoprofen group and within 35 minutes in the paracetamol group. Complete relief of pain was achieved within 30 to 40 minutes after ketoprofen in 28 patients (82.5%) compared to 5 patients (17.5%) in the paracetamol group. Six of the patients treated with ketoprofen needed a second dose for complete relief of pain during the 4-hour follow-up period. Side effects were rare and minimal. Our findings suggest that ketoprofen produced statistically significant benefit in the treatment of acute migraine. 相似文献
36.
37.
38.
39.
40.